7 Mar 2024
We are here to boost your immunotherapy and vaccine research with specialized antibodies. Make the next step in your research and learn more about us at: hubs.li/Q02nsdZN0 #BioTechRevolution #InnovateWithPMB #ProMabBioTech #ProMabBioEra
2
36
29 Feb 2024
mRNA-LNP has been a gamechanger in the biotechnology industry these coming years. We ensure reliability in delivering your genes! Contact us today and learn more at: hubs.li/Q02mK6Rj0 #BioTechRevolution#InnovateWithPMB#ProMabBioTech#ProMabBioEra
2
26
23 Jan 2024
20 years of expertise, 5,000 monoclonal antibodies—your path to groundbreaking research starts here. Elevate your project with ProMab. Contact us today and learn more at: promab.com #BioTechRevolution #InnovateWithPMB #ProMabBioTech #ProMabBioEra
3
30
18 Jan 2024
Developing antibodies like never before – where tradition meets AI. Your research deserves the best at ProMab Biotechnologies. Contact us today and learn more at: promab.com/custom-antibody-e… #BioTechRevolution #InnovateWithPMB #ProMabBioTech #ProMabBioEra
2
25
4 Jan 2024
Pioneering Excellence since 2001. Uncover the science behind our revolutionary journey—where innovation meets impact. Contact us today and learn more at: promab.com #BioTechRevolution #InnovateWithPMB #ProMabBioTech #ProMabBioEra
3
26
2 Jan 2024
ProMab Biotechnologies redefines biotech with groundbreaking antibodies, CAR-T/NK, mRNA-LNP. Contact us today and learn more at: promab.com #BioTechRevolution #ProMabBioTech
3
43
22 Mar 2023
🌟SELECTED Article🌟
CAR-T Cells Targeting Immune Checkpoint Pathway Players
By:
Vita Golubovskaya from @ProMabBiotech in #USA
🔍imrpress.com/journal/FBL/27/…
#immunology #immunotherapy #Checkpoint #cart #cell #tumor #CancerResearch
2
2
102
24 Nov 2022
🌟SELECTED Article🌟
CAR-T Cells Targeting Immune Checkpoint Pathway Players
By:
Vita Golubovskaya from @ProMabBiotech in #USA
🔍imrpress.com/journal/FBL/27/…
#immunology #immunotherapy #Checkpoint #cart #cell #tumor #CancerResearch
2
2
13 Sep 2022
$RGBP @TheRegenBio @ProMabBiotech Regen BioPharma, Inc. Begins Experiments Validating Its Proprietary CAR-T Cell Therapy prn.to/3S2ludU
1
11
9 May 2022
Welcome to read🆕CAR-T Cells Targeting Immune Checkpoint Pathway Players, by Vita Golubovskaya from @ProMabBiotech
imrpress.com/journal/FBL/27/…
#Checkpoint #immunotherapy #tumor #hematological_cancer #Cancer
3
3
16 Oct 2021
... and not all the cancers can be treated with this cell therapy yet
2
30 Mar 2020
I'm working with @ProMabBiotech on a #COVID19 drug, manufactured/ready for animal testing, and there are limited labs and capabilities out there to even do #SARSCoV2 testing. If FDA demands animal data, this is a huge bottleneck for entire industry, especially small biotechs.
5
1
8
15 Mar 2020
For any labs looking to conduct research on #COVID19, reagents are available. A PCR kit for #COVID19 testing is also available, @ProMabBiotech needs a clinical CLIA lab to validate for widespread distribution. Regulatory issues still blocking widespread distribution.
3 Mar 2020
ProMab’s products is available for COVID-19 research, ready to order!
#ncov2019 #novelcoronavirus #coronavirus #sarscov2 #covid19 #research
4
19 Feb 2020
Thrilled to announce our agreement with @ProMabBiotech which provides us access to an exciting, highly advanced humanized molecule to further the progress of our CB-011 CAR-T therapy. Find out more about the news here: bit.ly/38FokQ0
3
19 Jun 2018
#Delaware Bio member @ACROBio Announces Collaboration with @ProMabBiotech for #Immunotherapy Research. Read more: bit.ly/2JXL6pD
#netde #TechTuesday
1
2 May 2018
#IAmNotDead
Day 2 of 30 day cancer survivor challenge inspiredheroes.org/2018/05/0… #ISCT2018 #immunotherapy @BLLPHD @Gutkina @TmunityTx @NovartisCancer @ProMabBiotech @shirazziya @PennCancer
@ISCTglobal @alliancerm @biotechradar
1
3
8 Mar 2018
Are you developing T cell therapies? See how Vita Golubovskaya from @ProMabBiotech is developing cytotoxic CAR-T cells with decreased cytokine secretion at our #Cancer #Immunotherapy Symposium before the 2018 AACR Meeting. Promocode FIFTY for 50% off buff.ly/2G3sjIm
2
6 Jan 2018
Helix Biopharma signs binding letter of intent for #CART development with @ProMabBiotech #prevention #treatment #cancer | buff.ly/2lZvd7t
1
2
5 Jan 2018
Helix Biopharma signs binding letter of intent for CAR-T development with @ProMabBiotech #innovation #beatcancer | buff.ly/2CuZXnY
3
